The Dutch language version of the Pain Disability Index (PDI-DLV): psychometric properties in breast cancer patients.


Journal

Physiotherapy theory and practice
ISSN: 1532-5040
Titre abrégé: Physiother Theory Pract
Pays: England
ID NLM: 9015520

Informations de publication

Date de publication:
02 Sep 2023
Historique:
medline: 4 8 2023
pubmed: 5 4 2022
entrez: 4 4 2022
Statut: ppublish

Résumé

Pain after breast cancer surgery is a common and disabling problem. A reliable and valid questionnaire to assess pain-related disability is the Pain Disability Index (0-70). However, properties of the Dutch version (PDI-DLV) have never been investigated in this population. To assess psychometric properties of the PDI-DLV after breast cancer surgery. For reliability, relative and absolute reliability were calculated with a one-week test-retest interval, as well as internal consistency. Moreover, content and construct validity were examined to evaluate validity. One hundred twenty-three women were included. Relative reliability was good (intraclass correlation coefficient = 0.80). Standard error of measurement and minimal detectable change (absolute reliability) were 5.57 and 15.45 points, respectively. The mean difference between two measurements was -1.98 points, with 95% limits of agreement equal to 13.19 and -17.15. The within-subjects coefficient of variation was 59%. Internal consistency was confirmed (α = 0.87). The PDI-DLV was scored as understandable and complete (content validity). Construct validity was supported by confirmation of more than 75% of the tested hypotheses and of the one-factor model. The PDI-DLV is a valid questionnaire to assess pain-related disability 1 year after breast cancer surgery. Although absolute reliability is disputable, its good relative reliability allows evaluating changes between subjects.

Sections du résumé

BACKGROUND UNASSIGNED
Pain after breast cancer surgery is a common and disabling problem. A reliable and valid questionnaire to assess pain-related disability is the Pain Disability Index (0-70). However, properties of the Dutch version (PDI-DLV) have never been investigated in this population.
OBJECTIVE UNASSIGNED
To assess psychometric properties of the PDI-DLV after breast cancer surgery.
METHODS UNASSIGNED
For reliability, relative and absolute reliability were calculated with a one-week test-retest interval, as well as internal consistency. Moreover, content and construct validity were examined to evaluate validity.
RESULTS UNASSIGNED
One hundred twenty-three women were included. Relative reliability was good (intraclass correlation coefficient = 0.80). Standard error of measurement and minimal detectable change (absolute reliability) were 5.57 and 15.45 points, respectively. The mean difference between two measurements was -1.98 points, with 95% limits of agreement equal to 13.19 and -17.15. The within-subjects coefficient of variation was 59%. Internal consistency was confirmed (α = 0.87). The PDI-DLV was scored as understandable and complete (content validity). Construct validity was supported by confirmation of more than 75% of the tested hypotheses and of the one-factor model.
CONCLUSION UNASSIGNED
The PDI-DLV is a valid questionnaire to assess pain-related disability 1 year after breast cancer surgery. Although absolute reliability is disputable, its good relative reliability allows evaluating changes between subjects.

Identifiants

pubmed: 35378054
doi: 10.1080/09593985.2022.2059036
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2000-2014

Auteurs

Elien Van der Gucht (E)

Department of Rehabilitation Sciences, KU Leuven, University of Leuven, Leuven, Belgium.
Department of Rehabilitation Sciences and Physiotherapy, Movant, University of Antwerp, Belgium Campus Drie Eiken, Wilrijk, Belgium.
Pain in Motion International Research Group, Brussel, Belgium.

Lore Dams (L)

Department of Rehabilitation Sciences, KU Leuven, University of Leuven, Leuven, Belgium.
Department of Rehabilitation Sciences and Physiotherapy, Movant, University of Antwerp, Belgium Campus Drie Eiken, Wilrijk, Belgium.
Pain in Motion International Research Group, Brussel, Belgium.

Koen Bernar (K)

Department of Rehabilitation Sciences, KU Leuven, University of Leuven, Leuven, Belgium.
The Leuven Centre for Algology and Pain Management, University Hospitals Leuven, Leuven, Belgium.

Tessa De Vrieze (T)

Department of Rehabilitation Sciences, KU Leuven, University of Leuven, Leuven, Belgium.

Vincent Haenen (V)

Department of Rehabilitation Sciences, KU Leuven, University of Leuven, Leuven, Belgium.
Department of Rehabilitation Sciences and Physiotherapy, Movant, University of Antwerp, Belgium Campus Drie Eiken, Wilrijk, Belgium.

An De Groef (A)

Department of Rehabilitation Sciences, KU Leuven, University of Leuven, Leuven, Belgium.
Department of Rehabilitation Sciences and Physiotherapy, Movant, University of Antwerp, Belgium Campus Drie Eiken, Wilrijk, Belgium.
Pain in Motion International Research Group, Brussel, Belgium.

Lode Godderis (L)

Department of Public Health and Primary Care, Centre for Environment and Health, University of Leuven, Leuven Belgium.
External Service for Prevention and Protection at Work, IDEWE, Leuven, Belgium.

Bart Morlion (B)

The Leuven Centre for Algology and Pain Management, University Hospitals Leuven, Leuven, Belgium.
Department of Cardiovascular Sciences, Section Anaesthesiology & Algology, University of Leuven, Leuven, Belgium.

Mira Meeus (M)

Department of Rehabilitation Sciences and Physiotherapy, Movant, University of Antwerp, Belgium Campus Drie Eiken, Wilrijk, Belgium.
Pain in Motion International Research Group, Brussel, Belgium.
Faculty of Medicine and Health Sciences, Department of Rehabilitation Sciences and Physiotherapy, Ghent University, Ghent, Belgium.

Nele Devoogdt (N)

Department of Rehabilitation Sciences, KU Leuven, University of Leuven, Leuven, Belgium.
Department of Vascular Surgery and Department of Physical Medicine and Rehabilitation, Center for Lymphedema, Uz Leuven - University Hospitals Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH